Primary Care/Hospitalist
RSSArticles
-
Is Long-Term Alendronate Treatment a Problem?
This study emphasizes the need for increased awareness and monitoring for the potential development of excessive suppression of bone turnover during long-term alendronate therapy. -
Pharmacology Update: Exenatide Injection (ByettaTM)
The first of a new class of antidiabetic drugs has been approved for the treatment of type 2 diabetes mellitus. -
Folate: An Under-Rated Vitamin!
Increased intake of folate in any form is associated with a reduced risk of developing hypertension for women. -
Esomeprazole in Patients with Upper GI Symptoms Taking NSAIDs, Including COX-2 Inhibitors
Esomeprazole 20 mg and 40 mg daily improve upper GI symptoms occurring during NSAID therapy, including selective COX-2 inhibitors. -
Full May 29, 2005, Issue in PDF
-
Clinical Briefs
Management of asthma in America remains problematic, with as many as 5,000 deaths annually in recent years. -
Pharmacology Update: Micafungin Infusion (MycamineTM)
The FDA has approved a new intravenous antifungal agent. -
Asymptomatic Mitral Regurgitation: When is it Appropriate to Repair or Replace?
Patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery. -
Special Report: Bad News About the COX-2 Inhibitors
There has been enormous controversy regarding the benefit/safety relationship of the COX-2 inhibitors, which were initially introduced in 1999. This is a cautionary tale. -
What You Can't See Will Hurt You (and Your Patient)
Concealed renal insufficiency is common and contributes to adverse drug reactions from hydrosoluble medications.